196 related articles for article (PubMed ID: 12433703)
1. Differences in base excision repair capacity may modulate the effect of dietary antioxidant intake on prostate cancer risk: an example of polymorphisms in the XRCC1 gene.
van Gils CH; Bostick RM; Stern MC; Taylor JA
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1279-84. PubMed ID: 12433703
[TBL] [Abstract][Full Text] [Related]
2. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis.
Gann PH; Ma J; Giovannucci E; Willett W; Sacks FM; Hennekens CH; Stampfer MJ
Cancer Res; 1999 Mar; 59(6):1225-30. PubMed ID: 10096552
[TBL] [Abstract][Full Text] [Related]
3. Lycopene intake and prostate cancer risk: effect modification by plasma antioxidants and the XRCC1 genotype.
Goodman M; Bostick RM; Ward KC; Terry PD; van Gils CH; Taylor JA; Mandel JS
Nutr Cancer; 2006; 55(1):13-20. PubMed ID: 16965236
[TBL] [Abstract][Full Text] [Related]
4. DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk.
Stern MC; Umbach DM; van Gils CH; Lunn RM; Taylor JA
Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):125-31. PubMed ID: 11219769
[TBL] [Abstract][Full Text] [Related]
5. XRCC1 and XRCC3 polymorphisms and their role as effect modifiers of unsaturated fatty acids and antioxidant intake on colorectal adenomas risk.
Stern MC; Siegmund KD; Corral R; Haile RW
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):609-15. PubMed ID: 15767338
[TBL] [Abstract][Full Text] [Related]
6. XRCC1 polymorphism and lung cancer risk.
Schneider J; Classen V; Helmig S
Expert Rev Mol Diagn; 2008 Nov; 8(6):761-80. PubMed ID: 18999926
[TBL] [Abstract][Full Text] [Related]
7. A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer.
Shu XO; Cai Q; Gao YT; Wen W; Jin F; Zheng W
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1462-7. PubMed ID: 14693738
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy.
Shen M; Hung RJ; Brennan P; Malaveille C; Donato F; Placidi D; Carta A; Hautefeuille A; Boffetta P; Porru S
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1234-40. PubMed ID: 14652287
[TBL] [Abstract][Full Text] [Related]
9. A prospective study of XRCC1 (X-ray cross-complementing group 1) polymorphisms and breast cancer risk.
Patel AV; Calle EE; Pavluck AL; Feigelson HS; Thun MJ; Rodriguez C
Breast Cancer Res; 2005; 7(6):R1168-73. PubMed ID: 16457697
[TBL] [Abstract][Full Text] [Related]
10. Gene-environment interactions between the codon 194 polymorphism of XRCC1 and antioxidants influence lung cancer risk.
Ratnasinghe DL; Yao SX; Forman M; Qiao YL; Andersen MR; Giffen CA; Erozan Y; Tockman MS; Taylor PR
Anticancer Res; 2003; 23(1B):627-32. PubMed ID: 12680158
[TBL] [Abstract][Full Text] [Related]
11. Gene-environment interactions between the smoking habit and polymorphisms in the DNA repair genes, APE1 Asp148Glu and XRCC1 Arg399Gln, in Japanese lung cancer risk.
Ito H; Matsuo K; Hamajima N; Mitsudomi T; Sugiura T; Saito T; Yasue T; Lee KM; Kang D; Yoo KY; Sato S; Ueda R; Tajima K
Carcinogenesis; 2004 Aug; 25(8):1395-401. PubMed ID: 15044328
[TBL] [Abstract][Full Text] [Related]
12. Genetic variants of DNA repair genes and prostate cancer: a population-based study.
Ritchey JD; Huang WY; Chokkalingam AP; Gao YT; Deng J; Levine P; Stanczyk FZ; Hsing AW
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1703-9. PubMed ID: 16030105
[TBL] [Abstract][Full Text] [Related]
13. Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case-control study.
Hsing AW; Chen C; Chokkalingam AP; Gao YT; Dightman DA; Nguyen HT; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Stanczyk FZ; Reichardt JK
Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1077-82. PubMed ID: 11588134
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in DNA repair gene XRCC1 and increased genetic susceptibility to breast cancer.
Chacko P; Rajan B; Joseph T; Mathew BS; Pillai MR
Breast Cancer Res Treat; 2005 Jan; 89(1):15-21. PubMed ID: 15666192
[TBL] [Abstract][Full Text] [Related]
15. DNA-repair genetic polymorphisms and breast cancer risk.
Smith TR; Levine EA; Perrier ND; Miller MS; Freimanis RI; Lohman K; Case LD; Xu J; Mohrenweiser HW; Hu JJ
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1200-4. PubMed ID: 14652281
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review.
Hung RJ; Hall J; Brennan P; Boffetta P
Am J Epidemiol; 2005 Nov; 162(10):925-42. PubMed ID: 16221808
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk.
Zhou W; Liu G; Miller DP; Thurston SW; Xu LL; Wain JC; Lynch TJ; Su L; Christiani DC
Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):359-65. PubMed ID: 12692111
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms of DNA base-excision repair genes APE/Ref-1 and XRCC1 are not associated with the risk for Graves' disease.
Doğru-Abbasoğlu S; Tanrikulu S; Ademoğlu E; Erbil Y; Ozderya A; Karadağ B; Uysal M
Cell Biochem Funct; 2009 Oct; 27(7):462-7. PubMed ID: 19711438
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms and haplotypes of DNA repair genes in childhood acute lymphoblastic leukemia.
Pakakasama S; Sirirat T; Kanchanachumpol S; Udomsubpayakul U; Mahasirimongkol S; Kitpoka P; Thithapandha A; Hongeng S
Pediatr Blood Cancer; 2007 Jan; 48(1):16-20. PubMed ID: 16435384
[TBL] [Abstract][Full Text] [Related]
20. XRCC1 polymorphism and lung cancer risk in relation to tobacco smoking.
Schneider J; Classen V; Bernges U; Philipp M
Int J Mol Med; 2005 Oct; 16(4):709-16. PubMed ID: 16142409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
